Total Payments
$17,147
2024 Payments
$156.31
Companies
48
Transactions
395
Medicare Patients
4,066
Medicare Billing
$702,748
Payment Breakdown by Category
Food & Beverage$6,431 (37.5%)
Consulting$5,415 (31.6%)
Other$3,142 (18.3%)
Travel$1,416 (8.3%)
Education$742.97 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,431 | 367 | 37.5% |
| Consulting Fee | $5,415 | 3 | 31.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,960 | 1 | 11.4% |
| Travel and Lodging | $1,416 | 5 | 8.3% |
| Honoraria | $1,182 | 1 | 6.9% |
| Education | $742.97 | 18 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $3,776 | 47 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $3,421 | 36 | $0 (2024) |
| Exelixis Inc. | $2,842 | 13 | $0 (2019) |
| Blueprint Medicines Corporation | $1,182 | 1 | $0 (2021) |
| Incyte Corporation | $716.88 | 16 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $562.71 | 29 | $0 (2024) |
| Amgen Inc. | $441.15 | 29 | $0 (2023) |
| Genentech USA, Inc. | $424.08 | 32 | $0 (2020) |
| PFIZER INC. | $339.47 | 24 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $297.92 | 20 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $156.31 | 7 | AstraZeneca Pharmaceuticals LP ($44.41) |
| 2023 | $318.93 | 9 | Novartis Pharmaceuticals Corporation ($192.52) |
| 2022 | $125.00 | 1 | BeiGene USA, Inc. ($125.00) |
| 2021 | $1,194 | 2 | Blueprint Medicines Corporation ($1,182) |
| 2020 | $639.08 | 42 | Amgen Inc. ($117.61) |
| 2019 | $10,715 | 122 | E.R. Squibb & Sons, L.L.C. ($3,410) |
| 2018 | $1,784 | 102 | AstraZeneca Pharmaceuticals LP ($262.45) |
| 2017 | $2,215 | 110 | Incyte Corporation ($397.40) |
All Payment Transactions
395 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $17.46 | General |
| 11/01/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Oncology | ||||||
| 08/09/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: ONCOLOGY | ||||||
| 07/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Education | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 06/29/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Oncology | ||||||
| 01/04/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: Oncology | ||||||
| 12/15/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Oncology | ||||||
| 10/20/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Oncology | ||||||
| 09/20/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $104.00 | General |
| Category: Oncology | ||||||
| 09/15/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Oncology | ||||||
| 07/28/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Oncology | ||||||
| 05/19/2023 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Oncology | ||||||
| 05/15/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $34.10 | General |
| Category: Oncology | ||||||
| 04/20/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: Oncology | ||||||
| 03/24/2023 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), KISQALI | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: Oncology | ||||||
| 10/25/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 12/22/2021 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Honoraria | Cash or cash equivalent | $1,182.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 05/25/2021 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $11.97 | General |
| Category: ONCOLOGY | ||||||
| 10/06/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Oncology | ||||||
| 10/01/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Oncology | ||||||
| 09/30/2020 | GlaxoSmithKline, LLC. | BLENREP (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: ONCOLOGY | ||||||
| 09/29/2020 | Agios Pharmaceuticals, Inc. | TIBSOVO (Drug), IDHIFA | Food and Beverage | Cash or cash equivalent | $11.44 | General |
| Category: Oncology | ||||||
| 09/24/2020 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Oncology | ||||||
| 09/17/2020 | Lilly USA, LLC | CYRAMZA (Drug), VERZENIO, RETEVMO | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 924 | 1,995 | $670,485 | $184,853 |
| 2022 | 5 | 828 | 1,683 | $524,227 | $153,498 |
| 2021 | 6 | 691 | 1,285 | $495,874 | $121,132 |
| 2020 | 21 | 1,623 | 12,758 | $749,150 | $243,264 |
Total Patients
4,066
Total Services
17,721
Medicare Billing
$702,748
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 449 | 1,336 | $491,648 | $134,661 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 231 | 311 | $80,549 | $20,948 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $42,840 | $11,309 | 26.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 100 | $19,800 | $6,840 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 40 | $20,480 | $6,242 | 30.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $8,764 | $2,477 | 28.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $5,264 | $1,579 | 30.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 37 | 95 | $1,140 | $798.00 | 70.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 383 | 1,047 | $372,048 | $110,741 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 262 | 360 | $90,456 | $24,909 | 27.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 94 | 94 | $45,528 | $12,692 | 27.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 79 | $15,039 | $4,851 | 32.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 49 | 103 | $1,156 | $304.89 | 26.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 315 | 815 | $348,999 | $85,787 | 24.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 118 | 118 | $68,497 | $16,231 | 23.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 149 | 190 | $56,023 | $13,478 | 24.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 31 | 51 | $11,897 | $3,089 | 26.0% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 26 | 27 | $9,570 | $2,296 | 24.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 52 | 84 | $889.00 | $252.00 | 28.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 340 | 1,044 | $208,339 | $58,066 | 27.9% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 35 | 381 | $114,300 | $45,718 | 40.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 188 | 317 | $83,158 | $28,754 | 34.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 63 | 396 | $60,336 | $24,250 | 40.2% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2020 | 39 | 777 | $77,700 | $20,848 | 26.8% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2020 | 19 | 214 | $38,520 | $14,807 | 38.4% |
About Dr. Faisal Paracha, MD
Dr. Faisal Paracha, MD is a Specialist healthcare provider based in Kingston, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346299971.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Faisal Paracha, MD has received a total of $17,147 in payments from pharmaceutical and medical device companies, with $156.31 received in 2024. These payments were reported across 395 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($6,431).
As a Medicare-enrolled provider, Paracha has provided services to 4,066 Medicare beneficiaries, totaling 17,721 services with total Medicare billing of $702,748. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Hematology & Oncology
- Location Kingston, NY
- Active Since 05/10/2006
- Last Updated 01/22/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346299971
Products in Payments
- SPRYCEL (Drug) $3,211
- LYNPARZA (Drug) $2,897
- Cabometyx (Drug) $2,842
- AYVAKIT (Drug) $1,182
- OPDIVO (Biological) $345.82
- KEYTRUDA (Biological) $270.49
- JAKAFI (Drug) $266.98
- IMFINZI (Drug) $240.69
- BRUKINSA (Drug) $229.00
- KISQALI (Drug) $223.33
- TECENTRIQ (Biological) $211.99
- Revlimid (Drug) $208.46
- ELIQUIS (Drug) $175.03
- ALIMTA (Drug) $171.37
- SOLIRIS (Drug) $159.58
- Kyprolis (Biological) $148.89
- ADCETRIS (Biological) $131.41
- IBRANCE (Drug) $130.60
- Imbruvica (Drug) $125.75
- FASLODEX (Drug) $118.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Kingston
Dr. Michael Rittenberg, M.d, M.D
Specialist — Payments: $13,906
Specialist $13,906
Dr. Riolin Andrade, Md, MD
Specialist — Payments: $7,566
Specialist $7,566
Dr. Michael Hahn, M.d, M.D
Specialist — Payments: $4,129
Specialist $4,129
Dr. Marisa Orgera, Md, MD
Specialist — Payments: $1,275
Specialist $1,275
Maria Clavell
Specialist — Payments: $374.35
Specialist $374.35
Kirsten Wolff, Md, MD
Specialist — Payments: $143.51
Specialist $143.51